AMX0035
A35-008
Phase 2 small_molecule active
Quick answer
AMX0035 for Wolfram Syndrome is a Phase 2 program (small_molecule) at Amylyx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amylyx Pharmaceuticals
- Indication
- Wolfram Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active